The global AI in medical writing market size is expected to reach USD 2,072.30 million by 2032, according to a new study by Polaris Market Research. The report “AI in Medical Writing Market Share, Size, Trends, Industry Analysis Report, By Type (Scientific Writing, Clinical Writing, Type Writing), By End-use (Medical Devices, Pharmaceutical, Biotechnology), By Region, And Segment Forecasts, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growing acceptance of machine learning, particularly Artificial Intelligence (AI), in the healthcare industry is a key driver of market expansion. AI-powered solutions have shown significant potential in improving patient care, diagnostic accuracy, drug discovery, and treatment outcomes, leading to increased adoption by healthcare providers and pharmaceutical companies.
Additionally, the rising demand to reduce healthcare expenditures and the increasing R&D investments by pharmaceutical companies to optimize their processes and reduce costs are driving the market growth. AI-powered medical writing tools and solutions offer the potential to streamline various tasks, increase efficiency, and minimize manual efforts, ultimately leading to cost savings for healthcare organizations and pharmaceutical firms.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/ai-in-medical-writing-market/request-for-sample
During the COVID-19 pandemic, many pharmaceutical companies faced budgetary limitations due to economic uncertainties and healthcare system strain. As a result, they had to reevaluate their spending, including investments in research and development. This led to a reduction in R&D budgets and potentially affected their investment in traditional medical writing resources.
In response to the pandemic's challenges and the growing demand for innovative therapies, medical device, biotechnology, and life science companies recognized the need to invest in medical writers. They saw the potential of AI-powered medical writing tools to streamline and enhance the efficiency of the medical writing process. AI-driven solutions could help medical writers generate accurate and reliable reports, conduct literature reviews faster, and facilitate data extraction and summarization, all of which were essential during the pandemic.
As a result, there was an increasing intention among healthcare companies to boost their investment in AI-powered medical writing solutions to address the evolving demands of the healthcare industry during the COVID-19 pandemic and beyond. This increasing demand for AI in the healthcare industry was driven by the need for innovative and efficient solutions to cope with the challenges posed by the pandemic and to accelerate the development and dissemination of critical medical information.
AI in Medical Writing Market Report Highlights
Polaris Market Research has segmented the AI in medical writing market report based on type, end use, and region:
AI in Medical Writing, Type Outlook (Revenue - USD Million, 2023 - 2032)
AI in Medical Writing, End Use Outlook (Revenue - USD Million, 2023 - 2032)
AI in Medical Writing, Regional Outlook (Revenue - USD Million, 2023 - 2032)
Report Attributes |
Details |
Market size value in 2023 |
USD 722.75 million |
Revenue forecast in 2032 |
USD 2,072.30 million |
CAGR |
12.4% from 2023 – 2032 |
Base year |
2022 |
Historical data |
2019 – 2021 |
Forecast period |
2023 – 2032 |
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2032 |
Segments covered |
By Type, End Use, By Region |
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
Key companies |
Parexel International, Trilogy Writing & Consulting, Freyr, Cactus Communications, and GENINVO |
For Specific Research Requirements |